Spatial Biology Q&A with Arvind Rao

Share this article:

 

Arvind Rao Spatial Biology SpeakerA quick fire Q&A with ARVIND RAO, Professor of Computational Medicine and Bioinformatics, University of Michigan Ann Arbor, USA

Advancements in Spatial Biology

Q: What recent technological advancements in spatial biology do you find most promising for clinical applications?
High-plex spatial platforms like CODEX and Visium HD, combined with spatially resolved proteogenomics, are making it possible to extract clinically meaningful information directly from tissue architecture. These advances are bringing us closer to spatial biomarkers that can support diagnostics and treatment planning. The transition to subcellular level profiling (e.g. MERFISH technology) is changing the game substantially as well.

Q: How do you foresee spatial multi-omics transforming our understanding of complex diseases?
Spatial multi-omics allows us to capture gene, protein, and epigenetic information within the context of tissue structure. This integrated view helps reveal how localized microenvironments drive disease progression, therapeutic resistance, or immune evasion.

Applications in Disease Research

Q: Can you share insights on how spatial biology is being applied to neurodegenerative diseases and its potential impact on treatment strategies?
Spatial biology is helping map glial activation, neuronal loss, and regional inflammation across brain compartments in diseases like Alzheimer’s. These insights could lead to region-specific therapeutic targeting and better staging of disease progression.

Q: In what ways is spatial biology contributing to the development of personalized medicine approaches, particularly in oncology?
It enables identification of spatially distinct tumor niches—such as immune-silent or immune-excluded zones—that correlate with treatment response. This supports more tailored therapeutic strategies and stratification based on spatial context, not just molecular features.

Integration of AI and Machine Learning

Q: How are machine learning and AI being utilized to enhance the analysis and interpretation of spatial biology data?
AI tools are used for cell segmentation, niche detection, and spatial interaction modeling across large tissue datasets. They enable high-throughput, reproducible interpretation and integration of complex multi-modal spatial data.

Q: What challenges do you encounter when integrating AI tools into spatial biology research, and how do you address them?
We often face data heterogeneity, limited annotations, and model interpretability concerns. These are addressed using self-supervised learning, graph-based models, and frameworks that emphasize transparency and reproducibility.

Bioinformatics and Data Analysis

Q: What are the key considerations when developing computational tools for spatial data integration and visualization?
Scalability, spatial-awareness, and intuitive visualizations are key. Tools must also be modular to support integration of diverse data types like transcriptomics, proteomics, and pathology images.

Q: How do you approach standardizing spatial data to ensure consistency and reproducibility across studies?
We use harmonized pipelines, shared ontologies, and containerized workflows, alongside adoption of community standards like OME-NGFF. This ensures comparability and reproducibility across labs and platforms.

Future Directions and Challenges

Q: What do you identify as the primary challenges in advancing spatial biology from research to clinical practice?
The main challenges include lack of standardization, interpretability of results, and integration into clinical workflows. There’s also a need for regulatory-grade validation of spatial assays and analytics.

Q: Looking ahead, what developments or innovations in spatial biology are you most excited about?
I’m excited about AI-driven spatial diagnostics, agentic workflows for cross-modality interpretation, and integrated (bulk-singlecell- spatial) modeling of spatial omics networks. These could transform both discovery and clinical decision-making.

Personal Insights and Experiences

Q: Could you share a recent project or study where spatial biology provided unexpected insights or breakthroughs?
In our recent Proximogram study (https://www.sciencedirect.com/science/article/pii/S0010482524011673?via%3Dihub), we discovered that proximity patterns—not just presence—of immune and tumor cells revealed immune-exclusion zones across cancer tissues. These spatial gradients were invisible to standard cell counting approaches and opened new avenues for stratifying immune responsiveness.

Q: What advice would you offer to emerging researchers interested in specializing in spatial biology?
It would be good to learn to navigate both computational and biological domains, and stay grounded in meaningful scientific questions. Collaborate across disciplines and invest time in mastering spatial data interpretation, not just generation.

Hear Arvind at the International Spatial Biology Congress -The Hague or at the American Spatial Biology C0ngress – Philadelphia